Marie-Dominique GALIBERT Group

Gene Expression and Oncogenesis (GEO)

Marie-Dominique GALIBERT

Group Leader

> Email:

> Phone: +33 (0)2 23 23 47 05

The GEO team focuses on understanding the genetics mechanisms implicated in the transcriptional regulations that support tumour initiation and development. Two cancer diseases are under study : the UV-dependent skin cancers including melanoma and the ETV6/RUNX1-positive acute lymphoblastic leukemia (ALL).

Major publications

Selected Publications

  • A noncoding function of TYRP1 mRNA promotes melanoma growth. 
    Gilot D*, Migault M*, Bachelot L, Journé F, Rogiers A, Donnou-Fournet E, Mogha A, Mouchet N, Pinel-Marie ML, Mari B, Montier T, Corre S, Gautron A, Rambow F, El Hajj P, Ben Jouira R, Tartare-Deckert S, Marine JC, Felden B, Ghanem G and Galibert MD. 
    Nature Cell Biology. 2017 Nov. * Co-first author 

    CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling.
    Arnaud MP, Vallée A, Robert G, Bonneau J, Leroy C, Varin-Blank N, Rio AG, Troadec MB, Galibert MD and Gandemer V.
    Blood. 2015 Oct.

    p53 requires the stress sensor USF1 to direct appropriate cell fate decision.
    Bouafia A, Corre S, Gilot D, Mouchet N, Prince S and Galibert MD.
    PLoS Genet. 2014 May.


Subscribe to our newsletter